PAYS

NEUTRALEarnings

Paysign, Inc.

Price
$13.16
-6.60%

This is the 2026-08-27 snapshot — the signals and analysis for PAYS as of this single trading day.

View full PAYS research hub →
Score3.0Watchlist
Signals3/8 DNA0/13 Act · 1/4 Risk
SentimentNEUTRALScore: 8
Volume1.0xvs 20d avg

Analysis

PAYS is experiencing High-Conviction Price Discovery driven by a highly successful fundamental pivot toward high-margin healthcare payments, highlighted by an 85% YoY surge in its patient affordability business. Recent search data reveals that management's bullish presentation at the August 27th Midwest IDEAS Conference and a Zacks upgrade to 'Buy' are acting as immediate structural catalysts. These fundamental tailwinds perfectly align with the stock's flawless technical setup, evidenced by SURGE and PERFECT_STACK signals alongside a massive +46.9% 1-month gain. Supported by a RISK_ON macro regime where the market is actively rewarding high-beta earnings beats, institutional buyers are aggressively absorbing any valuation-based profit-taking.

Fired Signals

SURGEGOLDEN CROSSPERFECT STACKEXTENSION

Key Takeaways

  • Fundamental Pivot: PAYS is aggressively expanding its high-margin patient affordability business (up 85% YoY), successfully reducing reliance on its mature plasma payments segment.
  • Institutional Accumulation: Heavy buying from funds like Punch & Associates and recent analyst upgrades are overpowering insider selling and valuation-driven pullbacks.
  • Technical Strength: The PERFECT_STACK and SURGE signals align with a +41.3% relative strength vs SPY, making the $8.39 level a critical structural support floor for risk management.
© 2026 Signal52 • For educational purposes only